Novo Nordisk

“Gruber A/S is a most responsive partner, and we are very pleased with our cooperation”

– Novo Nordisk

Novo Nordisk is a global healthcare pharmaceutical  leader with over half a century of innovative processes and ground breaking techniques within diabetic care. Novo Nordisk also holds a leading position within hemophilia care, growth hormone therapy and hormone replacement therapy.  The Novo Nordisk business group has its corporate headquarters in Bagsværd, Denmark and employs approximately 35,000 employees in 75 countries and markets its products in 180 countries across the globe.

Bo Hallager who is technically responsible for the caps production has worked together with Gruber A/S for many years and praises the business relationship:

“Of course we have our own ideas when we want to develop new production equipment, but to attain the optimum solution we need a qualified team mate and an opponent when discussing the technological opportunities. Gruber A/S is such a partner, they are very responsive to our ideas and give positive, innovative feedback and suggestions in our collaboration. It is evident that Gruber has undergone dynamic developments over the recent years and we are very confident that our solid collaboration will continue with a renewed energy.

  Bo Hallager–Technical responsible Caps Production, Novo Nordisk